ACI Global Corporation ACI Global Corporation (ACGJ), a development-stage company headquartered in Greenwich, Connecticut and founded in 1997, focuses through its subsidiaries on the design and development of proprietary technology for producing synthetic rubber powder and thermoplastic elastomers under the Micropowder trade name. The company targets applications in the tire, plastic, and elastomer industries, where its Micropowder technology processes materials into fine powders for enhanced performance in manufacturing rubber products and chemical compositions; it operates primarily in the United States with potential for broader industrial applications. Previously known as Par Advance Technologies Corp., ACI Global has shifted from earlier biopharmaceutical pursuits involving synthetic and natural peptides for antimicrobial treatments, including candidates like P113D for cystic fibrosis and oral candidiasis prevention, to its current emphasis on materials science innovation, with no major acquisitions, partnerships, funding rounds, or product launches reported in the last 1-2 years.